GRP78 and Cripto form a complex at the cell surface and collaborate to inhibit transforming growth factor beta

Gidi Shani1, Wolfgang H Fischer, Nicholas J Justice

  • 1Clayton Foundation Laboratories for Peptide Biology, The Salk Institute, La Jolla, CA, 92037, USA.

Insights

Cripto and glucose-regulated protein 78 (GRP78) interact on cell surfaces, inhibiting transforming growth factor beta (TGF-beta) signaling. This collaboration enhances tumor growth, particularly in prostate cancer cells.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Protein Interactions

Background:

  • Cripto is a cell surface protein crucial for embryogenesis and tumor progression, modulating signaling pathways.
  • Existing Cripto binding partners do not fully account for its molecular functions.
  • Identification of novel Cripto-interacting proteins is necessary to elucidate its mechanisms.

Purpose of the Study:

  • To identify novel proteins that interact with Cripto.
  • To investigate the functional consequences of Cripto-GRP78 interaction.
  • To determine the role of Cripto and GRP78 in transforming growth factor beta (TGF-beta) signaling and tumor growth.

Main Methods:

  • Protein interaction screening to identify novel Cripto-binding partners.
  • Cell surface co-immunoprecipitation assays to confirm Cripto-GRP78 interaction.
  • Short hairpin RNA (shRNA) knockdown of GRP78 to assess TGF-beta signaling.
  • Analysis of Smad phosphorylation and prostate cancer cell proliferation under various conditions.
  • Soft agar assays to evaluate anchorage-independent growth.

Main Results:

  • Glucose-regulated protein 78 (GRP78), an ER chaperone, was identified as a novel Cripto-interacting protein.
  • Cripto and GRP78 interact at the cell surface, independent of ER association.
  • GRP78 knockdown enhances TGF-beta signaling, indicating GRP78's inhibitory role.
  • Coexpressed GRP78 and Cripto synergistically antagonize TGF-beta responses.
  • Prostate cancer cells coexpressing GRP78 and Cripto exhibit significantly enhanced anchorage-independent growth.

Conclusions:

  • Cripto and GRP78 form a cell surface complex that inhibits TGF-beta signaling.
  • This interaction promotes tumor growth, particularly anchorage-independent proliferation.
  • The Cripto-GRP78 complex represents a potential therapeutic target in cancer.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity: